A unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC). Use and re-distribution of the data, in whole or in part, for commercial purposes (including internal use) requires a license. DrugBank content is not a substitute for professional medical advice, diagnosis or treatment.
The Approved Drug Products with Therapeutic Equivalence Evaluations (also known as The Orange Book) identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.